Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 30 Central Nervous System Neoplasms 18 Rectal Neoplasms 15 Colorectal Neoplasms 15 Lung Neoplasms 13 Colonic Neoplasms 11 Carcinoma, Non-Small-Cell Lung 11 Stomach Neoplasms 9 Pancreatic Neoplasms 9 Glioblastoma 9 Gliosarcoma 7 Neoplasm Metastasis 6 Esophageal Neoplasms 6 Brain Neoplasms 6 Adenocarcinoma Of Esophagus 6 Carcinoma, Intraductal, Noninfiltrating 5 Breast Neoplasms, Male 5 Breast Carcinoma In Situ 5 Squamous Cell Carcinoma of Head and Neck 4 Sarcoma 4 Mesothelioma, Malignant 4 Kidney Neoplasms 4 Head and Neck Neoplasms 4 Carcinoma, Renal Cell 4 Astrocytoma 4 Uterine Cervical Neoplasms 3 Urinary Bladder Neoplasms 3 Solitary Fibrous Tumor, Pleural 3 Prostatic Neoplasms 3 Ovarian Neoplasms 3

Interventions

ribociclib 1 Tretinoin 1 Letrozole 1 Goserelin 1 Drug Therapy 1 Chemotherapy, Adjuvant 1 Anastrozole 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × HER2 Negative Breast Cancer × Chemotherapy, Adjuvant × Clear all

NCT06953882 2026-05-26

SELECT

Yale University

Phase 2 Recruiting

HER2 Negative Breast Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡